Vimarsana
Biggest News Aggregation in the World

Page 9 - Optune Lua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optune Lua Today - Breaking & Trending Today

FY2023 EPS Estimates for NovoCure Limited (NASDAQ:NVCR) Reduced by Leerink Partnrs - Vimarsana News

FY2023 EPS Estimates for NovoCure Limited (NASDAQ:NVCR) Reduced by Leerink Partnrs

NovoCure Limited (NASDAQ:NVCR – Free Report) – Leerink Partnrs decreased their FY2023 earnings estimates for shares of NovoCure in a report issued on Tuesday, November 28th. Leerink Partnrs analyst J. Chang now forecasts that the medical equipment provider will earn ($2.07) per share for the year, down from their prior estimate of ($2.00). The consensus […]

Leerink Partnrs Weighs in on NovoCure Limited's Q3 2024 Earnings (NASDAQ:NVCR) - Vimarsana News

Leerink Partnrs Weighs in on NovoCure Limited's Q3 2024 Earnings (NASDAQ:NVCR)

NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2024 EPS estimates for shares of NovoCure in a note issued to investors on Tuesday, November 28th. Leerink Partnrs analyst J. Chang expects that the medical equipment provider will post earnings per share of ($0.45) for the quarter. Leerink Partnrs […]

Financial Analysis: NovoCure (NASDAQ:NVCR) and Sintx Technologies (NASDAQ:SINT) - Vimarsana News

Financial Analysis: NovoCure (NASDAQ:NVCR) and Sintx Technologies (NASDAQ:SINT)

NovoCure (NASDAQ:NVCR – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Risk and Volatility NovoCure has a beta of […]

StockNews.com Upgrades NovoCure (NASDAQ:NVCR) to "Hold" - Vimarsana News

StockNews.com Upgrades NovoCure (NASDAQ:NVCR) to "Hold"

StockNews.com upgraded shares of NovoCure (NASDAQ:NVCR – Free Report) from a sell rating to a hold rating in a research note published on Friday. Several other research firms have also issued reports on NVCR. Wells Fargo & Company dropped their price objective on NovoCure from $102.00 to $49.00 and set an overweight rating on the […]

Source: wkrb13.com
NovoCure (NASDAQ:NVCR) Shares Up 7.2% - Vimarsana News

NovoCure (NASDAQ:NVCR) Shares Up 7.2%

NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares rose 7.2% during mid-day trading on Monday . The stock traded as high as $15.24 and last traded at $15.24. Approximately 445,283 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 1,394,237 shares. The stock had previously closed at $14.21. […]